Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

NASH News & Notes From The European Liver Meeting

Apr 16 2019

• By Joseph Haas

International Flags Blowing In Wind_1200x675

Related Content

Viking’s Liver Fat Reduction Data Portend A New Competitor In NASH

Sep 18 2018

NASH Drug Development Guidance Encourages Sponsors To Adopt Innovative Trial Designs

Dec 05 2018

Genfit Hopes To Make Case For First-Line Treatment In NASH

Apr 04 2019

Pfizer Thinks First-In-Class KHK Mechanism Could Work For NASH, Diabetes

Apr 15 2019

Gilead Increasingly Seems Focused On Combo Therapy In NASH

Apr 12 2019

Novartis’s NASH Chief: Our Strategy Is Combos With Tropifexor As ‘Backbone’

Apr 12 2019

Intercept's OCA Data Bolster NASH Efficacy, But Pruritus Worries Worsen

Apr 11 2019

NASH Pipeline: Racing To The Finish

Mar 21 2019

Madrigal Cements Case For Hepatic Fat Reduction, Other NASH Benefits With MGL-3196

Nov 13 2018

Related Companies

Intercept Pharmaceuticals, Inc.

Genfit SA

Laboratory Corporation of America

Madrigal Pharmaceuticals, Inc.

Viking Therapeutics, Inc.

Gilead Sciences, Inc.

Allergan plc

Additional Topics

Europe Research & Development Clinical Trials Business Strategies Liver & Hepatic Diagnostics BioPharmaceutical

More from Alimentary/Metabolic

More from Therapy Areas

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window